What is Cellebrite Di Ltd. share price today?

Cellebrite Di Ltd. (CLBT) share price today is {{live_price}}.

Can Indians buy Cellebrite Di Ltd. shares?

Yes, Indians can invest in the Cellebrite Di Ltd. (CLBT) from India. With INDmoney, you can buy Cellebrite Di Ltd. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Cellebrite Di Ltd. at zero transaction cost.

How can I buy Cellebrite Di Ltd. shares from India?

It is very easy to buy Cellebrite Di Ltd. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cellebrite Di Ltd. be purchased?

Yes, you can buy fractional shares of Cellebrite Di Ltd. with INDmoney app.

What are the documents required to start investing in Cellebrite Di Ltd. stocks?

To start investing in Cellebrite Di Ltd., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cellebrite Di Ltd.

Today’s highest price of Cellebrite Di Ltd. (CLBT) is {{1_rba_end}}. Today’s lowest price of Cellebrite Di Ltd. (CLBT) is {{1_rba_st}}.

What is today's market capitalisation of Cellebrite Di Ltd.

Today's market capitalisation of Cellebrite Di Ltd. CLBT is 4.0B

What is the 52 Week High and Low Range of Cellebrite Di Ltd.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Cellebrite Di Ltd. is down from its 52 Week High?

Cellebrite Di Ltd. (CLBT) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Cellebrite Di Ltd. is up from its 52 Week low?

Cellebrite Di Ltd. (CLBT) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Cellebrite Di Ltd.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Cellebrite Di Ltd.

Mr. Yossi Carmil is the current Chief Executive Officer (CEO) of Cellebrite Di Ltd..

Home>
US Stocks>
Cellebrite Di Ltd.

Cellebrite Di Ltd. (CLBT)

$18.04

-0.11

(-0.61%)▲

Live

Performance

$17.87
$18.23
$18.04
0.94%
Downside
Day's Volatility :1.95%
Upside
1.02%
$6.37
$18.76
$18.04
64.72%
Downside
52 Weeks Volatility :66.06%
Upside
3.81%

Returns

Period	Cellebrite Di Ltd.	Sector (Technology)	Index (Russel 2000)
3 Months	38.02%	4.5%	0.0%
6 Months	73.35%	19.9%	0.0%
1 Year	163.81%	40.9%	0.0%
3 Years	66.51%	45.3%	-23.0%

Highlights

Market Capitalization	4.0B
Book Value	-$0.19
Earnings Per Share (EPS)	-0.54
Wall Street Target Price	19.17

Profit Margin	-28.51%
Operating Margin TTM	13.05%

Return On Assets TTM	6.39%
Return On Equity TTM	-1768.51%

Revenue TTM	362.5M
Revenue Per Share TTM	1.86
Quarterly Revenue Growth YOY	24.8%
Gross Profit TTM	219.9M
EBITDA	61.0M
Diluted Eps TTM	-0.54
Quarterly Earnings Growth YOY	-0.77

EPS Estimate Current Year	0.4
EPS Estimate Next Year	0.37
EPS Estimate Current Quarter	0.05
EPS Estimate Next Quarter	0.08

Analyst Recommendation

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Cellebrite Di Ltd.(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 6.26%

Current $18.04

Target $19.17

Company Financials

	FY19	Y/Y Change
Revenue	171.9M	-
Net Income	-1.9M	-
Net Profit Margin	-1.09%	-

	FY20	Y/Y Change
Revenue	194.9M	↑ 13.42%
Net Income	5.8M	↓ 408.16%
Net Profit Margin	2.97%	↑ 4.06%

	FY21	Y/Y Change
Revenue	246.2M	↑ 26.34%
Net Income	71.4M	↑ 1135.01%
Net Profit Margin	28.99%	↑ 26.02%

	FY22	Y/Y Change
Revenue	270.7M	↑ 9.91%
Net Income	120.8M	↑ 69.2%
Net Profit Margin	44.63%	↑ 15.64%

	FY23	Y/Y Change
Revenue	325.1M	↑ 20.12%
Net Income	-81.1M	↓ 167.13%
Net Profit Margin	-24.95%	↓ 69.58%

	Q1 FY23	Q/Q Change
Revenue	74.0M	↑ 0.0%
Net Income	7.1M	↑ 0.0%
Net Profit Margin	9.56%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	84.2M	↑ 13.73%
Net Income	6.5M	↓ 8.17%
Net Profit Margin	7.72%	↓ 1.84%

	Q3 FY23	Q/Q Change
Revenue	84.2M	↑ 0.0%
Net Income	6.5M	↑ 0.0%
Net Profit Margin	7.72%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	89.6M	↑ 6.42%
Net Income	-71.4M	↓ 1198.03%
Net Profit Margin	-79.67%	↓ 87.39%

	Q1 FY24	Q/Q Change
Revenue	95.7M	↑ 6.85%
Net Income	-23.8M	↓ 66.64%
Net Profit Margin	-24.88%	↑ 54.79%

	Q2 FY24	Q/Q Change
Revenue	95.7M	↑ 0.0%
Net Income	-23.8M	↑ 0.0%
Net Profit Margin	-24.88%	↑ 0.0%

	FY19	Y/Y Change
Total Assets	280.2M	-
Total Liabilities	221.4M	-

	FY20	Y/Y Change
Total Assets	364.4M	↑ 30.03%
Total Liabilities	300.6M	↑ 35.76%

	FY21	Y/Y Change
Total Assets	339.8M	↓ 6.75%
Total Liabilities	413.1M	↑ 37.44%

	FY22	Y/Y Change
Total Assets	403.3M	↑ 18.69%
Total Liabilities	329.4M	↓ 20.26%

	FY23	Y/Y Change
Total Assets	540.4M	↑ 34.0%
Total Liabilities	506.2M	↑ 53.66%

	Q1 FY23	Q/Q Change
Total Assets	403.3M	↑ 0.0%
Total Liabilities	329.4M	↑ 0.0%

	Q2 FY23	Q/Q Change
Total Assets	476.9M	↑ 18.26%
Total Liabilities	439.0M	↑ 33.26%

	Q3 FY23	Q/Q Change
Total Assets	476.9M	↑ 0.0%
Total Liabilities	439.0M	↑ 0.0%

	Q4 FY23	Q/Q Change
Total Assets	529.1M	↑ 10.94%
Total Liabilities	555.8M	↑ 26.62%

	Q1 FY24	Q/Q Change
Total Assets	556.6M	↑ 5.19%
Total Liabilities	596.7M	↑ 7.36%

	Q2 FY24	Q/Q Change
Total Assets	556.6M	↑ 0.0%
Total Liabilities	596.7M	↑ 0.0%

	FY19	Y/Y Change
Operating Cash Flow	16.1M	-
Investing Cash Flow	-46.7M	-
Financing Cash Flow	75.5M	-

	FY20	Y/Y Change
Operating Cash Flow	66.5M	↑ 312.26%
Investing Cash Flow	-6.4M	↓ 86.2%
Financing Cash Flow	-8.6M	↓ 111.38%

	FY21	Y/Y Change
Operating Cash Flow	36.1M	↓ 45.79%
Investing Cash Flow	45.2M	↓ 801.29%
Financing Cash Flow	-68.4M	↑ 695.96%

	FY22	Y/Y Change
Operating Cash Flow	20.6M	↓ 42.92%
Investing Cash Flow	-91.2M	↓ 301.72%
Financing Cash Flow	14.0M	↓ 120.42%

	Q1 FY23	Q/Q Change
Operating Cash Flow	35.7M	↑ 0.0%
Investing Cash Flow	-10.7M	↓ 71.31%
Financing Cash Flow	2.0M	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	29.2M	↓ 18.37%
Investing Cash Flow	-10.7M	↑ 0.0%
Financing Cash Flow	8.8M	↑ 344.35%

	Q3 FY23	Q/Q Change
Operating Cash Flow	29.2M	↑ 0.0%
Investing Cash Flow	-10.9M	↑ 1.42%
Financing Cash Flow	8.8M	↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Cellebrite Di Ltd. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cellebrite Di Ltd.	4.91%	73.35%	163.81%	66.51%	77.07%
Microsoft Corporation	-3.54%	4.29%	26.98%	34.56%	202.07%
Palantir Technologies Inc	13.23%	104.91%	165.25%	73.41%	352.32%
Palo Alto Networks, Inc.	8.91%	33.07%	52.26%	121.36%	429.74%
Adobe Systems Inc.	-6.25%	6.0%	-8.42%	-22.51%	85.47%
Oracle Corp.	5.27%	52.53%	68.52%	81.4%	216.87%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cellebrite Di Ltd.	69.09	NA	NA	0.4	-17.69	0.06	NA	-0.19
Microsoft Corporation	35.26	35.26	2.25	11.8	0.37	0.15	0.01	36.12
Palantir Technologies Inc	247.06	247.06	2.17	0.35	0.11	0.04	NA	1.81
Palo Alto Networks, Inc.	51.35	51.35	2.73	5.57	0.75	0.03	NA	15.9
Adobe Systems Inc.	42.07	42.07	1.63	18.28	0.35	0.16	NA	32.69
Oracle Corp.	45.02	45.02	2.13	5.59	1.56	0.07	0.01	3.9

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cellebrite Di Ltd.	Buy	$4.0B	77.07%	69.09	-28.51%
Microsoft Corporation	Buy	$3.1T	202.07%	35.26	35.96%
Palantir Technologies Inc	Hold	$94.1B	352.32%	247.06	16.32%
Palo Alto Networks, Inc.	Buy	$122.0B	429.74%	51.35	32.11%
Adobe Systems Inc.	Buy	$218.7B	85.47%	42.07	25.59%
Oracle Corp.	Buy	$484.1B	216.87%	45.02	20.4%

Insights on Cellebrite Di Ltd.

Increasing Revenue
Revenue is up for the last 10 quarters, 62.38M → 95.71M (in $), with an average increase of 4.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -71.37M → -23.81M (in $), with an average increase of 99.9% per quarter
Vs PLTR
In the last 1 year, Palantir Technologies Inc has given 166.7% return, outperforming this stock by 5.5%
Vs PANW
In the last 3 years, Palo Alto Networks, Inc. has given 73.4% return, outperforming this stock by 6.9%